Croquet Launches Edge Collaboration Platform and Global Developer Infrastructure for Creating Real-Time, Multi-User Web and Mobile Applications
24.8.2021 14:00:00 EEST | Business Wire | Press release
The world’s perception of what real-time collaboration can actually look like is about to change. Croquet Corporation, the technology leader in Edge Collaboration (a new, rapidly-growing sector of Edge Computing) has launched the Croquet Collaboration Platform™ allowing developers worldwide to create multi-user apps with real-time capabilities never before possible.
While Croquet’s exclusive mission is delivering developer tools and infrastructure – including the Croquet Library, APIs and highly useful frameworks – the company has launched a free reference app called PiiX (Photo Instantaneous Interactive Experience) to showcase the technology. PiiX allows anyone, from consumers to sophisticated developers, to test-drive this revolutionary new collaboration technology right now, with no registration required.
Scan a QR code and watch as PiiX, a real-time, collaborative annotation app jumps instantly onto your phone or tablet. Invite others and as you annotate or manipulate the image, the results appear simultaneously in real-time on all participant screens. All users have simultaneous control. Users often describe the experience as “magical”. But it’s the global infrastructure underneath, with frameworks on top, that make everything possible. Click here to try PiiX.
“We believe that all future applications should be collaborative – including apps for productivity, social collaboration, telemedicine, sports, interactive marketing, AR/VR, SaaS, gaming, you name it,” says David A. Smith, Founder & CTO of Croquet. “With this launch, Croquet is delivering all of the tools and infrastructure developers need to easily build mind-blowing, real-time, fully synchronous collaborative apps that make today’s multi-user apps look like anachronisms. We expect that developers will find amazing ways to use this technology that we haven’t even imagined yet.”
Croquet was funded in early 2020 to pursue development and private beta testing of the infrastructure, libraries, tools and reference app launched today. Use cases for the technology are vast and varied across startups, the enterprise, commercial applications, social collaboration, media, marketing, interactive advertising and social games. See more use case detail on the Croquet website.
A Peek Under the Hood
Croquet’s first-of-its-kind Edge Collaboration infrastructure is deployed globally today on every continent (except Antarctica). It provides a super-fast reflector-based network (with latency as low as 10-15ms, depending on location), as well as a unique edge collaboration protocol and synchronization service that enable real-time collaboration at the edge of the network where performance is best. Servers have long stood between users and real-time collaboration. With Edge Collaboration, nothing runs on servers so developers are free to easily create apps for instantaneous shared experiences.
All the “smarts” of the application are on the client side. Each user is operating a shared virtual machine, with everyone’s device guaranteed to run the exact same program at exactly the same time, in exactly the same way. These client-side, bit-identical virtual machines use a replicated computation model that enables ultra-low latency, low bandwidth synchronization and instantaneous interactions.
Applications generate events which are sent to an Edge Reflector, the architectural center of the Croquet infrastructure, which then redistributes it to each session participant’s replicated virtual machine, providing precise synchronization with exceedingly low latency. Reflectors are small pieces of software that sit on the Edge and are spun up or down as needed anywhere in the world to support high performance sessions. Croquet Infrastructure is highly scalable with reflectors running across the globe, all designed to work with existing online and mobile networks, including 5G. Developers can sign up here to receive a free key allowing them to start using Croquet.
“Croquet is the best thing I’ve seen in computing over the last 15 years,” says Alan Kay, an advisor to Croquet since its inception, and Turing Award Winner long considered Father of the Personal Computer. “It solves massive problems associated with building real-time collaborative applications in extremely elegant ways. The Internet has been needing this for many years.”
Other key facts about the Croquet Library, API and frameworks include:
- No back-end code; simple front-end, client-side only. Easy for even novice programmers
- Fast and simple to implement. Changes the entire multi-user app development dynamic so developers can build and deploy multi-user apps in days, not months
- Application state is automatically shared so new users can join a live session instantly
- Abstracts the developer from powerful underlying infrastructure; it just works
- Multiple frameworks available for critical tasks
- Works globally with extremely low latency
- Privacy-focused; every message is encrypted end-to-end. The servers only see encrypted data; so even leaks would do no harm to privacy
- No timing issues or out-of-order events. Croquet uses “replicated computation” to eliminate message “collisions”
- Edge reflectors exist as software and have no application state; they are extraordinarily scalable globally and can function as a self-proliferating network
- View this technical FAQ on the Croquet website
Development of the company’s current technology was led by Smith and co-founders Vanessa Freudenberg, Aran Lunzer, Yoshiki Ohshima and Brian Upton – a team of architects and engineers in Los Angeles, CA.
“This is an amazing team that has built something remarkable,” says John Payne, CEO of Croquet. “The Croquet Platform and Infrastructure will enable a whole new breed of applications that couldn’t exist before while supporting the addition of collaboration features to existing applications around the world in a highly scalable way.”
The market for collaboration technology as a whole is massive. COVID has accelerated demand by 10 years, but so far the technology has lagged. Croquet changes the conversation, enabling a huge leap forward in developing Instantaneous Shared Experiences.
About Croquet
Croquet Corporation – the technology leader in Edge Collaboration, a new, rapidly-growing sector of Edge Computing – operates a global Edge Collaboration Platform and Collaboration Infrastructure that enables developers to quickly and easily create a vast range of multi-user collaboration apps for web and mobile, at virtually limitless scale. Croquet has its spiritual roots in work begun in the 1990’s by Founder & CTO David A. Smith, Alan Kay, David P. Reed and Andreas Raab in the Croquet Project, an open source 2D/3D environment for collaborative work written in Smalltalk. Croquet was formed in 2019 and funded by SIP Global Partners and a group of experienced technology and financial industry veterans. Visit www.croquet.io.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210824005340/en/
Contact information
Media/Analyst Contact: Daniel Kehrer: daniel.kehrer@croquet.io
Partnerships Contact: Stu Kozlowski: stu@croquet.io
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 01:10:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of ORZEYFUL marks a new chapter for the narcolepsy type 1 community, as we introduce an entirely new class of medicine that will potentially redefine how this disease is managed and howpeople feel on treatment,” said Julie Kim, president and chief executive officer of Takeda. “We are proud to have discovered and developed this orexin treatment innovation and will bring it to adults living with NT1 as quickly as possible.” NT1 is a rare, chronic neurological disease d
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 23:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 17:05:00 EEST | Press release
Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership, and operational excellence with a track record of execution from first-in-human studies through regulatory
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 17:00:00 EEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
Speech Processing Solutions Launches Philips SpeechLive Legal AI Assistant for Faster, More Accurate Legal Document Creation5.8.2026 16:37:00 EEST | Press release
Speech Processing Solutions, the global leader in AI-assisted professional dictation and documentation solutions sold under the Philips brand, today announced the Philips SpeechLive Legal AI Assistant. The new solution transforms voice recordings, dictation and uploaded sources into structured, ready-to-review legal documents, helping legal professionals work faster while retaining control of the final draft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805997413/en/ The new Philips SpeechLive Legal AI Assistant is designed for turning conversations into ready-to-review legal document drafts. SpeechLive Legal significantly reduces the time needed to transform voice input into structured legal documentation, delivering consistent and high-quality drafts and featuring SpeechLive's built-in integrations with leading case management platforms such as Actionstep, Clio, iManage and NetDocuments, supporting existing billing, e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
